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The association of a toxin or toxic factor with a Virus has never been demon- 
strated  although  it may have been  suspected.  In fact,  under  most circum- 
stances it is difficult to devise experiments which would  demonstrate clearly 
the  occurrence  of a  toxin in  association with  these agents  since both would 
be of small size and  usually of labile nature.  Thus, ff all possible sources of 
confusion were controlled, a positive result would be of great value but a nega- 
tive  one  would  be without  significance. 
For many reasons it has been suspected in  this  laboratory that the agent 
of lymphogranuloma venereum, and the other agents which have been shown 
to be closely allied to it  (1-5)  should be separated from the true viruses and 
established  in  a  group by themselves,  comparable to  the  Rickett~  for ex- 
ample  (6).  It had  also been suspected  that  the  agent  of lymphogranuloma 
venereum at least, with which we have had most experience, produces a  toxin. 
In the acute form of generalized infection with this latter agent in man, chills, 
severe headache, and marked prostration occur and the whole picture suggests 
a  toxemia (7,  8).  Furthermore,  in the laboratory, the convulsive deaths oc- 
curing  in  mice within  30  hours  after intracerebral  infection  (9)  are difficult 
to account for by the lesions present in the meninges, and the cause of death in 
the chick embryo after infection of the yolk sac has always seemed due pos- 
sibly to toxemia since the  agent does not invade the embryo to any marked 
extent  (10),  and  careful studies  have shown  that no significant  disturbance 
of nutrition results from the infection of the yolk ceils (11). 
The work of Gildemeister and Haagen (12) on the toxin associated with Rickettsia 
mooseri grown in the yolk sac of the chick embryo stimulated anew our interest in this 
problem.  These authors found that suspensions  of yolk sacs heavily infected with 
R. mooseri, when suspended in Ringer's solution,  were  lethal for  mice.  Following 
intraperitoneal inoculation of 0.5 to 1.0 ml. of such suspensions  the mice died in 4 to 
48 hours, often with convulsions.  Smaller amounts were less active and illtracerebral 
or subcutaneous inoculation was less  effective  than intraperitoneal.  The toxic sub- 
stance was very labile and could not be demonstrated after the suspensions  had been 
treated in any manner which killed the Rickettsiae.  Serum from individuals who had 
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suffered from endemic or epidemic typhus neutralized the toxin, and so did placental 
globulin.  Serum from individuals immunized against typhus had some activity, but 
serum from normal human beings or rabbits had no neutralizing power.  The authors 
believed they might be dealing with an endotoxin. 
In our laboratory it has been possible  (13)  to demonstrate a  toxin, or toxic 
factor,  closely associated  with  the  bodies  of the  agents  of lymphogranuloma 
venereum,  of meningopneumonitis  (Francis  and  Magill  (14)),  and  of mouse 
pneumonitis  (15,  16).  1 
As will be shown in the present paper,  these toxic factors behave like bac- 
terial endotoxins and they will therefore be referred to as toxins. 
Tech.iq~ 
All inoculations into the chick embryo, whether to obtain toxin or to titrate infective 
units, have been made by the yolk sac route  into fertile eggs previously incubated 6 
days, employing volumes of 1 ml.  Suspensions of yolk sacs have been made by shak- 
ing them without beads  for 30  minutes in a  machine.  In  all but the early experi- 
ments yolk sacs to be shaken were suspended in  their own yolk and fluids (with the 
egg albumen carefully excluded) at a volume of 1 in 2.5, 1 in 5, or 1 in 10 of their origi- 
nal weight after draining off excess yolk.  Further  2-fold dilutions were made in a 
variety of diluents, discussed below, but for most purposes pooled yolk, allantoic fluid, 
and amniotic fluid from normal 6 day chick embryos were used.  In titrating infective 
units 10 eggs have been used on each dilution and  dilutions increased by 2-fold incre- 
ments.  The LD50 was calculated by the method of Reed and Muench (17)., 
All intravenous inoculations into mice were made in one of the tail veins after these 
had been dilated by immersion of the tail in hot water.  Except in early experiments 
a volume of 0.5 ml. was used in every case.  Mice were examined at frequent intervals 
and  deaths recorded in hours after inoculation.  Deaths  during the night were re- 
corded as between so and so many hours (e.g. between 6 and 20 hours) and given a 
median value (e.g. 13 hours).  In titrating toxic units 10 mice were used on each dilu- 
tion, the dilutions were increased by 2-fold increments, and the L~50  calculated by 
the method of Reed and Muench (17). 
Tissues for microscopic examination were fixed in Zenker's fluid.  Only tissues from 
mice known to have died within 30 minutes were used for pathological examinations. 
Eosin and methylene blue stain has been employed as routine, with special stains, 
such as Weigert's fibrin stain for renal capillary thrombi, used as occasion demanded. 
Maechiavello's stain has been employed for all smears of yolk sacs.  Selection of yolk 
sacs for maximal toxin content has been based on the heaviness of infection indicated 
by smears prepared from a fragment of such sacs.  This point is discussed in detail 
below. 
1 The strain of mouse pneumonitis used in the present  studies  was the Atherton 
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The  Toxin from  the Agent of Lymphogranuloma Venereum 
Following the inoculation of a suspension of the agent of lymphogranuloma 
venereum into  the yolk sac  of the  chick,  the yolk cells become heavily in- 
fected  (18).  By  adjusting  the  inoculum,  the  time  of  death  from  specific 
infection  can be  gauged very accurately (10).  It  is  found  that when yolk 
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sacs are harvested shortly before or after death of the embryo, suitably diluted 
suspensions of those found by yolk sac smears to be heavily infected are lethal 
for mice following intravenous inoculation of 0.5 ml. amounts.  The time of 
death varies, of course, with any given suspension, with the degree of dilution 
and type of diluent, and with the presence, or absence, of partial neutraliza- 
tion with serum.  Deaths may occur as early as 4 hours after inoculation and 
are very rare after 36 hours.  Text-fig. 1 shows  the distribution  of time of 
death  obtained  by  combining all  the  experiments,  involving  860  mice.  83 466  LYM'P~0  GRANULOMA  VENEREIY~[.  11 
per cent of deaths occur by 24 hours and 95 per cent by 36 hours.  Some of 
the  early deaths  are accompanied by convulsions but  for the most part the 
mice become lethargic with very labored breathing and death comes quietly. 
In the case of both the agent of lymphogranuloma and the other agents dis- 
cussed below, other tissues and fluids from the eggs were tested for the presence 
of the  toxin,  but,  except in  the  case of the yolk,  toxin is absent  or present 
in amounts too small to be lethal.  The yolk is sometimes toxic intravenously 
in  0.5  ml.  amounts  undiluted.  Normal yolk is  not  toxic under  like  condi- 
tions.  Even in the yolk sac itself the toxin is present in comparatively low 
concentration.  Thus 0.5 ml. of a dilution of 1 in 40 of original weight of yolk 
sac was toxic in only 9 of 42 experiments and 1 in 80 was never toxic.  1 in 20 
was toxic slightly  less than 50  per cent  of the  time although,  as conditions 
which would inactivate the toxin became understood,  the percentage of tests 
giving some deaths at  1 in 20 could be increased. 
2 m|. amounts of 1 in 5  suspensions of heavily infected yolk sacs kill mice 
by the intraperitoneal route.  Time of death and symptoms are similar to what 
is seen after intravenous inoculation.  Higher dilutions have been ineffective 
by this route. 
The  susceptibility  of mice varies with  the  weight.  This is  demonstrated 
more particularly with  the  toxin  from the  agent  of meningopneumonitis  in 
which  higher  toxicity per gram  of infected  yolk sac  (see below)  allows  the 
demonstration  of greater variation between  mice at  different  weight  levels. 
For practical purposes mice of 12 to 14 gm. were used in most tests; although 
smaller mice are killed with less toxin,  there  are practical  difficulties in  the 
rapid intravenous inoculation of large numbers of these very small animals. 
Mice dying from toxemia show congestion of the lungs in the case of early deaths 
and enlarged yellow  livers in  those dying at 20  hours or later.  Microscopically,  the 
most constant features in deaths up to 9 hours are scattered hemorrhages in the lung 
or patches of edema fluid in the alveoli, and fibrin thrombi in the glomerular capillaries 
of the kidney.  In addition,  one sees occasionally  necrosis  of cells in some cortical 
tubules and exudate in the glomerular spaces and tubules of the kidney.  The liver 
shows very occasional foci of frank necrosis and more frequent foci in which the cells 
appear damaged, and are loaded with fat droplets but not yet necrotic (Fig.  1).  In 
deaths occurring at 15 to 24 hours, hemorrhage or edema in the lung is rare.  No fibrin 
thrombi are seen in the kidney but there is occasional tubular damage.  Small loci 
of accumulated glial cells, seen in the cerebrum of about one-third of mice examined, 
may represent a specific lesion.  The most prominent damage, however, is in the liver. 
In almost every case there are numerous foci of necrosis throughout the organ (Fig. 2). 
Such foci are often accompanied by hemorrhage and whatever hepatic ceils are not 
necrotic usually show marked cloudy swelling.  In many cases it is difficult to deter- 
mine the position of the necrosis in the liver lobule, but, in cases in which this can be 
established,  it is always midzonal. GEOFFREY  RAKE AND HELEN  P. JONES  467 
The toxin is labile and is inactivated by many comparatively simple treat- 
ments.  Thus it disappears in eggs which die and are allowed to remain at 
36°C.  Inactivation  is  slower  at  room  temperature  (approximately  22°C.) 
but even here activity may drop 50 per cent in 4 or 5 hours.  Small amounts 
of  certain  detergent  soaps  remaining  in  washed  glassware  will  destroy  all 
toxicity,--a cause of much worry in the early stages of the present investigation 
and  one  which  has  been  overcome  by  using  only  acid-cleaned  glassware. 
Treatment with 0.1  per cent formalin destroys all  toxicity but not all anti- 
genicity (see below).  Even the choice of diluent is very important.  Besides 
the usual mixture of yolk and egg fluids,  others have been used.  Of these, 
physiological saline and beef heart infusion broth produce some inactivation 
of  the  toxin.  Normal  serum,  of  human,  bovine,  or  lapine  origin,  is  even 
better than yolk and egg fluids in preserving full toxicity.  However, many 
normal bovine sera, which were the most readily available, when given intra- 
venously to mice in 0.5 ml. amounts, produce agglutination and hemolysis of 
red cells with rapid death and cannot be used for routine work. 
Toxin can be stored at various low temperatures for future use.  Most in- 
vestigation  of optimal  conditions for storage has  been  carried out with  the 
toxin  of meningopneumonitis and  will be discussed below.  With  the  toxin 
of lymphogranuloma venereum most satisfactory storage is at 0°C. 
No toxicity of the type described above can be demonstrated in freshly pre- 
pared  or  stored  suspensions  of  normal  yolk  sac.  Similarly  the  high-speed 
sediment of normal yolk sacs shows no such toxicity.  It is true that normal 
embryo yolk and  fluids,  the  usual  diluent  employed,  often  effect the  mice 
particularly after storage in the cold.  This is especially true when care has 
not been taken to exclude albumen from the fluid mixture, and the reaction 
can be avoided if the fluid diluent is centrifuged for 20 minutes at 1800  R.P.M. 
However, the nature of this reaction differs from the action of the toxins under 
consideration in  that  the mice show  immediate symptoms with  convulsions 
or extreme prostration, and death or recovery supervenes in a few minutes. 
The reason for considering the material producing death in the mice receiving 
infected yolk sac  suspensions  as  a  toxin  is  discussed  below.  At  this  point 
attention should be drawn  to those observations which indicate that we are 
not  dealing with  an  infection.  Foremost  of these  is  the rapidity of death. 
Included in Text-fig. 1 is a distribution curve of time of death of mice infected 
intracerebraUy  with  the  agent  of  lymphogranuloma  venereum--the  most 
rapid method of infection known--obtained by combining many experiments 
totaling 2750 mice.  This should be compared with the curve of toxic deaths. 
From infection no  deaths occur before 21  hours have elapsed and  only 0.7 
per cent in the first 24 hours (83 per cent in the case of the toxin).  24 per cent 
of deaths take place in the first 36 hours (toxin 95 per cent),' and deaths con- 
tinue to occur for 3 weeks, accompanied by all degrees of chronic infection. 468  LYMIPIIOGRANULOMA  VENEREU~L  II 
Similar delayed deaths do not follow intravenous or intraperitoneal inoculation. 
The mice either die rapidly or soon become ~vell.  In fact limited experiments 
indicate that these mice, having received intravenously high concentrations of 
yolk sac material, which not merely is toxic but contains large numbers of viral 
bodies potentially infectious by other routes, do not become carriers, despite 
the relative ease with which the carrier state is set up in mice surviving in- 
fection (9, 19).  The agent is not demonstrable by the most sensitive methods 
of detection in the brain or spleen of mice surviving sublethal doses of toxin. 
The changes  found in  the  tissues  also  speak  against  death  from  infection. 
All of those described above are such as are usually associated with administra- 
TABLE  I 
Ratio of Toxic to Infective Units under Various Conditions 
Agent 
Lymphogranu- 
lom£t  venereum 
Ct  ~ 
Meningopneu- 
monifis 
tC 
Treatment 
Freshly harvested 
Cg  g¢ 
g~  gg 
¢¢  c¢ 
-72°C. 
11 days 
~-72°C. 
35 days 
--72°C. 
85 days 
Frozen and thawed six 
times 
~so 
Infectivity for 
chick embryos 
1/370 million 
1/260  " 
1/265  " 
1/nso  " 
1/1560 
1/495 
1/210 
1/210 
1/125 
I~50 
l'oxicit: ' 
[or mio 
1/13 
1/7.7 
1/6.2 
1/33 
1/43 
1/43 
1/45 
1/24 
1/17 
Toxicity/ 
infecticity ratio 
1/28  million 
1/34  " 
1/43  " 
1/36  " 
1/36  " 
1/11.5  " 
1/4.7  " 
1/8.8  " 
1/7.4  " 
tion of a  toxic material.  No evidence of any inflammatory change, or other 
alteration usually associated with viral or bacterial infection, is present. 
Attempts  have  been made  by  three  principal  methods  to  determine  the 
nature of the toxin.  Everything done so far indicates that it is closely associ- 
ated with the actively infectious bodies of the agent.  Thus filtration of sus- 
pensions of infected yolk sacs through Seitz pads, which hold back the infec- 
tive agent (20), results in atoxic filtrates.  Moreover, when infected yolk sacs 
suspended in infected yolk are first centrifuged at 1500 g.P.~., and the super- 
hate from this recentrifuged at 18,000  R.P.~.  for 1 hour in the cold, the toxin 
remains with the final sediment of elementary bodies and is not found in the 
supernate from which 99 per cent of the agent has been removed (18).  It has, 
in fact, proved possible to wash and resuspend the sediment repeatedly with 
full retention of toxicity.  Finally, simultaneous  titration of the number of GEOFFREY RAKE AND HELEN P. JONES  469 
toxic units (for mice) and infective units (for eggs) in a given freshly harvested 
yolk sac suspension has revealed that these bear a  relationship to each other 
which is as constant from test to test as could be expected in biological tests 
of this nature (Table I).  As will be pointed out below, no complete separation 
of toxic and infective factors has yet been accomplished, but in the case of 
the agent of meningopneumonitis certain manipulations result in decrease of 
infectivity with retention of toxicity. 
The Toxin from the Agent of Meningopneumonitis 
Following the same technique as that described for the agent of lympho- 
granuloma venereum, it has proved possible to demonstrate a toxin associated 
with the agent of meningopneumonitis, first isolated and described by Francis 
and Magill (14).  The toxin in this case can be demonstrated in higher dilution 
by intravenous inoculation than can the toxin of lymphogranuloma, although 
routine  smears  of yolk sacs  always  suggest  a  lighter  infection in  meningo- 
pneumonitis.  Thus a  dilution of 1 in 40 of yolk sacs by weight was toxic in 
77 of 98 tests killing 233 of 442 mice, and a dilution of 1 in 80 was toxic in 41 of 
84 tests killing 97 of 374 mice.  Dilutions of 1 in 20 or less were almost always 
fatal, killing all of the mice.  Even a dilution of 1 in 160 was toxic in 5 of 41 
tests and such high titers can probably be obtained more frequently by the use 
of normal lapine or human serum. 
The distribution of the toxin in the tissues and fluids of the embryo is similar 
to  that  of  the  toxin  of  lymphogranuloma.  As  might  be  expected,  higher 
titers than with lymphogranuloma venereum can be obtained with the yolk 
from meningopneumonitis, which is occasionally toxic at a dilution of 1 in 10. 
2 ml. amounts of freshly harvested yolk sacs are toxic for mice intraperi- 
toneally in far higher dilution than is the case with yolk sacs infected with 
lymphogranuloma.  The endpoint tends to be less sharp by this route than by 
the intravenous  (Table II). 
As stated above, the susceptibility of mice to those toxins of agents of the 
lymphogranuloma-psittacosis group which have been tested differs with weight. 
Table III shows the result of a titration with the toxin of meningopneumonitis. 
Two  explanations  exist  for  the  higher  fiters  of  toxin found  in  meningo- 
pneumonitis.  Either  the  agent  of meningopneumonitis  is  more  toxic  than 
is that of lymphogranuloma, infective unit for infective unit, or it is not more 
toxic but its infective units are present in greater amount in infected yolk sacs. 
That the latter explanation is correct is shown by the data in Table I.  As 
will be seen, the number of toxic units per gram of freshly harvested infected 
yolk sacs bears a  constant relationship to the number of infective units, and 
the toxicity-infectivity ratio for both agents is as close as could be expected 
from such biological experiments.  The agent of meningopneumonitis is present 
in greater amounts in such yolk sacs than is the agent of lymphogranuloma. 
The time of death of mice inoculated intravenously with the yolk sac sus- 470  LYMPHOGRANULOMA  VENEREUM,  1I 
pension of meningopneumonitis differs markedly in one respect from the time 
with the yolk sac suspension of lymphogranuloma.  It will be seen from Text- 
fig. 2 that there is no sharp end to the mortality but that deaths continue for 
as long as 3 weeks.  As might have been predicted, these deaths, unlike those 
with  the  suspension  of  lymphogranuloma,  are  due  to  infection  as  well  as 
toxemia.  At first it seemed impossible to separate deaths due to the one cause 
TABLE IX 
Comparison of To.city of geningopneumonitis  Material by the Intravenous and 
Intraperitoneal Routes 
Intravenous  Intrapetitoneal 
Date of test 
1/160 
6/14/43 
6/21/43 
7/ 6/43 
8/3/43 
8/16/43 
8/30/43 
9/ 2/43 
1110 
5/5* 
3/3 
5/S 
5/5 
5/5 
1/20  1/40  1/80 
3/3  3/3  4/4 
4/4  4/4  2/4 
5/5  4/5 
5/s  5/5  4/s 
5/5  5/s 
5/5  5/5  3/5 
1/160 
1/5 
0/4 
1/5 
5/5 
4/4 
10/10 
5/5 
1/10 
2/5 
3/5 
10/1~ 
3/5 
5/S 
3/5 
1/20  I  1/40 
-~-/S-- 
3/4 
5/9  0/4 
s/5  3/4 
3/5  3/5 
1/80 
0/4 
2/5  0/S 
* 5/5 -  S mice of 5 inoculated died within 60 hours. 
TABLE III 
Toxicity  of Meningopnenmonitis  Material in Mice of Different Weights 
Weight of mice 
gm. 
10--12 
12-14 
15-17 
20-22 
Dilution of toxin 
1/10 
6/6 
4/4 
6/6 
1/20 
5/6 
4/6 
5/6 
4/6 
1/40 
s/6 
2/6 
2/6 
0/6 
1/s0 
2/6 
0/6 
0/6 
0/6 
11150 
o/6 
0/6 
o/6 
0/6 
from those due to the other, but it has not proved difficult.  As Text-fig. 2 
shows,  the first part  of the  curve follows closely that  of lymphogranuloma 
venereum  but  the  curve rises  again  at  72  hours.  The  appearance  of  the 
mice suggests that this latter rise is due to infection and such an assumption 
is  borne  out  by  the  microscopical findings  and  by  the  neutralization  tests 
which  will  be  discussed  later.  Even  sera  of  high  titer,  which  completely 
prevent deaths in the first 60 hours, i.e., those deaths comprising the first part 
of the curve, fail in most instances to prevent the later deaths.  As the curve 
of distribution of time of death following the use of antitoxic sera shows (Text- 
fig. 2), the distribution in this case covers the same range as the second, or GEOI~FILEY RAKE AND IIELEN  P, JONES  471 
infectivity, rise described above.  For practical purposes, therefore, all deaths 
occurring up to 60 hours have been considered as toxic deaths and none later 
have  been  so  considered.  This  obviously introduces  the  error  of including 
some infective  deaths  and  excluding a  few  toxic deaths  around  the  60 hour 
period  but  such  errors  probably  counterbalance  each  other. 
Mice  dying  from  the  toxin  of meningopneumonitis  show  symptoms  very 
similar to those described for that of lymphogranuloma venereum.  The later 
infectious  deaths  are  preceded  by  characteristic  symptoms  of infection with 
ruffled fur,  hunched  back,  and  marked  loss  of weight. 
30  --  -  Menin~neurnoniti5  I 
25  /~  No. of mice- 3,090.  [ 
=-----e  IV  inocuLation of  t=in  alone[ 
'  ~  J'---&  IV inoculation of  toxin and  I 
neutralizing  dilutions  of antitoxin I 
,  I  No. of  mfce- 307.  I 
s ° 
-  I  2.  3  4  5  I0  15  20  2.5 
Days  = 
2O 
I0 
5 
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The lesions  found in mice receiving yolk sac suspensions of meningopneumonitis 
intravenously are striking.  In the early deaths, both before 12 hours and up to 60 
hours, the macroscopic appearances resemble those seen following inoculation of the 
agent of lymphogranuloma.  The bright yellow livers suggest extensive necrosis.  In 
later  deaths  the macroscopic changes in  the liver may become even more striking 
because  of regeneration  of new  liver  lobules;  in  addition,  pin-point,  plum-colored 
areas appear in the lungs, and the spleen is often large and soft, or may show yellowish 
grey areas.  In deaths as late as 7 days the surface of the brain appears dull and the 
brain itself is swollen  and softer than usual. 
Microscopically, changes in the organs in deaths up to 21 hours are similar to those 
seen  following inoculation  of the agent  of lymphogranuloma venereum.  Thus,  in 
deaths within 6 hours, fibrin thrombi are found in the renal glomerular capillaries and 
there is fluid in some pulmonary alveoli.  Damaged fat-holding cells are found in the 
midzonal region of the hepatic lobule at 4 hours and by 6 hours a few foci of frank 
necrosis are present.  During the next 12 hours the areas of hepatic necrosis become 
more extensive and are definitely midzonal in distribution  (Fig. 3).  In the kidney 
there is damage to some cortical tubules with death of some cells.  At 25 hours the 472  LYMPHO  GRANULOM'A VE1WEREIY~.  II 
hepatic lesions are even more extensive but a new lesion, necrosis of the Malpighian 
corpuscles, has appeared in half of the spleens examined.  At 39 to 44 hours hepatic 
changes  are the same as at 25 hours.  In the lung not only is fluid present in the 
alveoli, as often occurs in early deaths, but in many areas there is frank hemorrhage 
as well.  The splenic changes are similar to those seen at 25 hours.  By 48 hours a 
new feature has appeared, namely, resolution  of the areas of hepatic necrosis.  Other 
lesions are the same as before except that the areas of necrosis in the spleen are defi- 
nitely larger (Fig. 4).  By 66 to 71 hours the resolution  of areas of hepatic necrosis is 
being followed by regeneration of lobules.  In the lung an early interalveolar mono- 
cytic infiltration is present in most cases and there is an early monocytic infiltration 
of the cerebral pia mater (Fig. 5.).  Thus the first signs of infection are evident at this 
stage.  At 90 to 94 hours some of the spleens  examined show areas of necrosis often 
taking  up  whole  Malpighian  corpuscles,  while  other  spleens  show  an  appearance 
resembling acute splenic tumor, the whole pulp being filled with monocytes.  In the 
lung definite though small foci of monocytic consolidation  are found and loci of mono- 
cytic infiltration are present in the cardiac muscle and pericardium (Fig. 6).  In some 
cases the Kupffer cells of the liver are distended with viral vesicles  (10) (i.e.,  little 
colonies of the agent in the cytoplasm).  Other changes are as before.  By 7 days the 
areas of necrosis in the liver have disappeared for the most part and there is marked 
regeneration of lobules.  The meningitis is much more extensive and the monocytic 
infiltration includes the choroid  plexus and the linings of the ventricles.  Some peri- 
vascular cuffing is apparent.  Foci of monocytic infiltration are present in the cortex 
of the kidney. 
It will be noted  that  the  early lesions found  following inoculation  of  the 
agent  of  meningopneumonitis  resemble those found following inoculation  of 
the agent of lymphogranuloma and are undoubtedly due to the toxin.  Start- 
ing at about 60 hours there are found lesions which are due to infection, namely, 
the  meningitis,  the  interalveolar infiltration and loci of consolidation  in  the 
lungs,  the monocytic infiltration of the cardiac muscle and the cortex of the 
kidney, and the acute splenic tumor.  It is interesting to note that the lesions 
in the lung and the  central  nervous system resemble closely those described 
by Francis and MagiU (14)  as beng produced by the agent of meningopneu- 
monitis.  They do not note having seen the lesions which we believe to be due 
entirely to the toxin, namely, those in the liver and kidney. 
Following administration of the toxin by the intraperitoneal  route,  lesions 
are found which  resemble  those  seen  after intravenous  inoculation,  namely, 
necrosis in the liver and fluid in the pulmonary alveoli.  Particularly marked 
is the destruction of the cells of the renal cortical tubules. 
It has not been possible to demonstrate lesions in the organs of chick em- 
bryos moribund  or recently dead  after yolk sac inoculation  with  the  agent. 
If,  therefore,  the  death  of the embryo is due  to  toxicity,  it must occur too 
rapidly for lesions to  be produced  (as in the most rapid deaths  in mice)  or 
the tissues of the embryo must fail to respond in a manner similar to those of 
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The  lability  of  the  toxin  of  meni'ngopneumonitis  resembles  that  of  the 
toxin of lymphogranuloma.  For the most satisfactory tests yolk sacs from 
moribund embryos should be used, but appreciable amounts of toxin can be 
demonstrated in yolk sacs of embryos known to have been dead for not more 
than 3  or 4  hours."  Table IV gives the data of representative tests for the 
TABLE IV 
Stability of tke Menlngopneumonitis Toxln under Various Conditions of Storage 
Date of 
preparation 
5/ 4/43 
cc 
6/14/43 
4C 
7/26/43 
Date of testing 
5/ 4/43 
5/11/43 
~t 
7/28/43 
6/14/43 
6/13/43 
6/17/43 
6/21/43 
7/22/43 
7/24/43 
6/15/43 
6/22/43 
7/22/43 
6/15/43 
6/22/43 
7/22/43 
7/23/43 
8/ 6/43 
9/15/43 
7/26/43 
8/30/43 
9/27/43 
Condition  of 
storage 
°C. 
--32 
--72 
0 
cc 
--32 
c~ 
-72 
~c 
~t 
tc 
tc 
0 
c~ 
1/lO 
0/4 
4/4 
9/9 
5/5 
5/5 
5/5 
5/5 
5/5 
3/5 
5/5 
5/5 
5/5 
5/5 
5/5 
4/4 
4/4 
5/5 
9/9 
4/4 
4/4 
4/4 
Dilution of toxin 
1/20 
2/3* 
0/4 
3/4 
6/9 
5/5 
5/5 
4/4 
5/5 
1/5 
0/5 
3/5 
1/5 
2/5 
3/5 
3/5 
5/5 
5/5 
4/5 
3/lo 
o/4 
5/5 
2/5 
1/4o 
3/3 
0/4 
0/4 
0/10 
1/3 
5/5 
415 
3/5 
215 
015 
o/4 
115 
1/5 
2/5 
1/5 
1/5 
O/4 
0/lC 
0/4 
1/5 
o/5 
t/8o  1/16o 
~/4 
~/4 
o/9 
~/5 
2/5 
1/5 
1/5 
o/5  0/5 
o/3  o/5 
0/5 
0/5 
0/5 
0/4 
* 2/3  =  2 mice of 3 inoculated  died within 60 hours. 
retention of toxicity after storage at various low temperatures.  It will be seen 
that when material is stored in rubber-stoppered, dope-sealed  2 tubes at -- 72°C. 
in dry ice there may be an initial loss in potency, but thereafter the potency 
remains approximately unaltered over a  period of 3  months.  It is essential 
that the tubes stored in this manner be carefully sealed with rubber stoppers 
and airplane dope since 9therwise rapid inactivation will occur, owing prob- 
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ably to a  pH alteration.  At  -32°C.  there is an even greater initial loss of 
potency and for this reason this storage temperature has not been employed. 
On storage at 0°C. the toxicity usually shows an initial increase which appears 
within 24 to 48 hours.  This may be due to slow liberation of elementary bodies 
from previously intact yolk ceils.  Full  activity is  then  usually  maintained 
over periods as long as 2 months, the longest period of test, although occasion- 
ally there  may be an  abrupt  and  as yet unexplained  loss  in  potency.  For 
practical purposes storage either at  --72°C. or 0°C. has been adopted. 
As has been pointed out above, the constant ratio between toxic and infec- 
tive  units  has  held  only  with  freshly harvested  yolk  sacs.  Attempts  have 
been made to  separate completely toxic action  and  infectivity, without  any 
success.  The  toxin  is  so  labile  that  any  manipulation  which removes  all 
infectivity also  removes all  toxicity.  However, with  the  agent of meningo- 
pneumonitis partial separation has been achieved.  Thus, as is shown in Table 
I, the simple process of storing yolk sac suspensions at  -72°C.  decreases the 
infectivity in contrast to the toxicity so that the toxicity-infectivity ratio de- 
creases from about  1 to 37 million to about 1 to 8 million, a  decrease which 
is  consistent  and  significant.  Moreover,  repeated  freezing  and  thawing  of 
freshly harvested material has the same effect (Table I). 
The  Toxin from  the Agent  of Mouse  Pneumonitis 
Studies have also been made on the agent of mouse pneumonitis  (15,  16). 
The  distribution  of  time of  death  following  intravenous  injection  with  sus- 
pensions of this agent  (Text-fig. 3)  is quite  unlike  that of the two  discussed 
above.  The greater number of deaths  (21 per cent of the 233  mice included 
in Text-fig. 3 and 29 per cent of the 309 mice studied up to the present) occurs 
in the first 4 hours and then no more deaths occur before 30 hours have elapsed. 
It seems clear that we are dealing with a  toxin more intensely lethal for the 
animals than are either of the others since it kills the mice so rapidly.  These 
mice recover from the injection and remain apparently well for about 30 minutes. 
They then become sick and are rapidly prostrated and die.  The deaths occur- 
ring at 30  to 48 hours also follow only a  short period  of obvious illness and 
the mice behave as though they were suffering from a toxemia.  Later deaths 
are characteristic of infection with this agent.  The animals show ruffled fur, 
extreme loss of weight, and they have a hunchbacked high gait. 
A scrutiny of the lesions found in these mice offers some explanation of the signs 
observed.  Mice dying in the early period, i.e. up to 4 hours,  show none macroscopi- 
cally or microscopically.  In those dying between 30 and 60 hours the liver is bright 
yellow and friable while occasional pin-point, plum-colored lesions may be seen in the 
lungs.  In such mice microscopic examination reveals areas of early interstitial pneu- 
monia with patches of edema fluid in the alveoli.  There may be a few necrotic tubules 
in the renal cortex and in one case this process was very extensive.  As in the case of GEOFFREY RAKE AND HELEN P.  ]ONES  475 
the other agents, however, the most intense damage is that in the liver.  This follows 
the usual pattern of necrosis spreading out from the midzone of the lobule.  There is 
one striking and characteristic feature, namely, distension of the Kupffer cells with 
viral vesicles.  It would appear that this represents removal of elementary and initial 
bodies of the agent from the blood stream by the Kupffer cells, with subsequent mul- 
tiplication of the agent until the cytoplasm of these cells is filled with vesicles.  The 
necrosis of the liver ceils, appearing as late as it does, would seem to be due to the toxic 
action of these accumulations of the agent in the Kupffer cells. 
In mice dying on the 3rd or 4th days after inoculation the macroscopic appearance 
of the liver is unaltered.  The spleen is very large and consolidation in the lung is 
more obvious.  Microscopically, the changes in the liver are of the type described 
above but are more advanced.  Those liver cells which are not necrotic show marked 
30~ 
25  --  IVlouse Pneumonitis 
IV  inoculation  of  toxin 
2o  No. of mice-233. 
~  15 
I  2  3  4  5  I0  15  20  2.5 
Days 
T~xT-Fm. 3 
cloudy swelling.  There are occasional  foci of  monocytes.  In  the  spleen  there is 
commencing necrosis in the  Malpighian corpuscles, and viral vesicles  are present in 
some of the  endothelial  ceils  of the  sinuses.  In the  lung, besides  focal interstitial 
infiltration  of monocytes, there are fluid and fibrin in the alveoli. 
In still later deaths, i.e. 7 days or later, a characteristic finding is generalized subcu- 
taneous edema, ascites, and pleural effusion.  The liver is very large and as much as 
50 per cent of the lung may show consolidation.  Microscopically, the liver shows 
early cirrhosis with infiltration by fibroblasts and commencing regeneration of liver 
lobules.  In focal areas the alveoli of the lung contain monocytes and a few neutrophils 
--a typical lobular pneumonia.  Other lesions are inconstant and their significance of 
some doubt.  Thus in one case there were foci of necrosis in the cardiac muscle, and 
in  another  two  small  areas  of  complete  destruction  of  hippocampal  cells  in  the 
cerebrum. 
The rapid deaths, i.e.,  those up to 4 hours have occurred only with dilutions 
of yolk sac of I in 2.5 or 1 in 5.  AswiU be pointed out below, routine smears of 476  LYm~HOGP.ANULOMA  VENEP~U~.  n 
yolk sacs have  shown  a  lighter infestation with  this agent  than  occurs with 
either  lymphogranuloma  venereum  or  meningopneumonitis.  Titration  of 
infected yolk sacs by the yolk sac route in chick embryos also indicates that 
infestation of the yolk cells is less with this agent than with the other members 
of  the  group  thus  far  studied.  This  apparently accounts  for  the  low  titer 
of toxin.  Infectivity occurs with  dilutions of 1  in 40  or even occasionally 1 
in 80. 
As with  the  other  agents,  toxin can  be obtained from  eggs with  embryos 
moribund or recently dead.  The optimal storage conditions for the toxin are 
the same as for meningopneumonitis. 
Neutralization  Tests with Serum 
Following  immediately  upon  the  demonstration  of  the  toxins  described 
above,  antisera  were  prepared.  Rabbits  were  injected  intravenously  with 
fresh  untreated  suspensions  of  infected yolk  sacs,  similar to  those  used  for 
demonstrating toxicity in mice except that normal saline was used as diluent. 
In addition, rabbits were injected intravenously and chickens intravenously or 
intraperitoneally  with  formalin-treated  toxoid.  Tests  showed  that  such 
formalin-treated material was non-toxic for mice and non-infective for eggs. 
The  schedule for both rabbits and  chickens consisted of three consecutive daily 
injections of increasing amounts  of toxin or toxoid.  Injections of toxin or toxoid 
began at 0.1 ml. of a 10  -2 dilution made up to a volume of 1 ml. in physiological saline 
and increased to 0.2 ml. and 0.3 ml. of a  10  -2 dilution for the first 3 day period.  This 
was followed by a 4 day rest and injections were then resumed on the 5th day at 0.1 
ml. of a  10  -x dilution.  Increments from then on were as before (i.e. 0.2 ml. and 0.3 
ml. of a  10  -I dilution) and after the 4 day rest period injections were resumed at the 
dose given in the last inoculation before the rest period (i.e. 0.3 ml. followed by 0.4 
ml. and 0.5 ml. of a  10  -1 dilution).  Three such series were given and the animal then 
rested for 3 weeks.  A  new series of injections was then begun.  Some animals re- 
ceived as many as five 3  week series of inoculations.  Trial bleedings were  taken 
on the day that a new series of injections was begun and before such injections were 
made.  During the 3 week rest period trial bleedings were taken on the 5th day after 
the last inoculation and again on the day that a new series of injections was started. 
Toxoid was prepared by mixing equal amounts of highly toxic yolk sac suspensions, 
diluted 1 to 5 in their own yolk and fluids, with 0.2 per cent formalin in physiological 
saline.  This mixture was allowed to stand at 37°C. for at least 24 hours before use and 
was stored at 0°C. 
Two methods of neutralization have been used.  In the first the mice (weighing 
between 12 and 14 gin.) have been given intravenously 0.25 ml. of a given dilution of 
antitoxic serum in physiological saline followed within  5  minutes by 0.25  ml. of a 
suspension of toxin at a  concentration presumed sufficient to give a dose of 2 M.L.D. 
As a  control, mice received 0.25 ml. of physiological saline or normal rabbit serum 
followed by toxin.  The number of X~.L.D. in the toxin is titrated at the same time. 
In the second method equal amounts of a given dilution of antitoxie serum in normal GEO~FI~REY RAKE AND HELEN P. ~ON~S  477 
yolk and fluids, and suspension of toxin diluted with normal yolk and fluids to contain 
approximately 4 M.T..D. per 0.5 ml., are thoroughly mixed and left for 2 hours at room 
temperature.  Mice (12  to 14 gin.)  are then inoculated intravenously with 0.5 ml. 
amounts of these mixtures.  As controls,  and to determine the exact number of toxic 
units used, mice are inoculated with mixtures of equal parts of the same toxic suspen- 
sions  and of normal human or rabbit serum in the same dilution  as the test sera. 
These controls, after standing at room temperature for 2 hours, are further diluted 
2-fold, 4-fold, and 8-fold in normal yolk and fluids  and then inoculated in 0.5  ml. 
amounts.  None of the normal human or lapine sera tested so far have shown  any 
neutralizing power against any of the toxins.  In the second  method an occasional 
apparent inconsistency appears with  the  higher dilutions  of inactive sera.  These 
will seem to protect mice while lower dilutions  show no protection.  It can, however, 
be demonstrated that this phenomenon is due to diluting out the serum and thus losing 
some of the protective power which normal or inactive serum has on the toxin (see 
above).  If the toxin is present in quantities just sufficient to produce death in the 
presence of higher serum concentrations, too low a concentration of serum will result 
in survival of some mice. 
Since both of the methods outlined  above give good and comparable neu- 
tralization  (Table V),  the second method  of neutralization  in ~itro has been 
adopted  as  a  routine  for the  sake of simplicity.  It is  clear,  however,  that 
passive transfer of protection is possible and, in fact, in the case of the toxin 
of meningopneumonitis, which kills in quite high dilution after intraperitoneal 
inoculation (Table II), one can give the toxin intraperitoneaUy and protect the 
mice  by  intravenous  injection  of  antiserum  given  immediately  before  the 
administration of toxin. 
The toxin of lymphogranuloma venereum has never proved as good an anti- 
gen as has that of meningopneumonitis.  Thus in rabbits the highest titer of 
antiserum, produced with fresh toxin of the former agent, which gives complete 
protection has been 1 in 10 against 2 lethal doses of toxin, and no response was 
obtained with  toxoid in one rabbit.  Only toxoid has been used in chickens 
and here a titer of 1 in 10 after 3 series of injections was the maximum obtained. 
On  the  other hand,  inoculation  with fresh  toxin of meningopneumonitis has 
given titers in rabbits as high as 1 in 200 against 2 or 3 lethal doses after as few 
as 2 or 3 series of injections.  Toxoid in rabbits has given titers as high as I in 
80 after 2 series of injections and in a chicken a titer of 1 in 250 against 2 lethal 
doses after 4  series of injections.  These titers, however, are only against the 
toxin.  These antitoxic sera show little if any protection against the infection 
which follows intravenous inoculation of yolk sacs infected with the agent of 
meningopneumonitis. 
The striking  thing  has  been  the  absence  of any cross-neutralization  with 
these antitoxic sera.  Table VI shows representative cross-neutralization tests 
with rabbit and chicken sera.  In only one of all sera examined, namely, the 
one bleeding from rabbit 60 shown in Table VI, was there any evidence of cross- TABLE  V 
Neutralization in Viro and in Vitro of the Toxin of Lyraphogranuloraa 
Venereum 
Inr~ro 
In vitro 
0.25 ml. R 54 
sle/r  2 iun~  sdialliutn~  d]  0.25 ml. saline 
Followed by 0.25 ml. toxin 
S,* S, S. S, S 
Toxin -4-  R 64 
serum diluted 
I/2 
S, S, S, S, S 
<17~, <17, <17,  <17,  42 
Control 
0.5 ml. toxin in normal yolk and fluids 
Diluted 2-fold 
<18, <18, <18 
Diluted 4-fold  Diluted  8-fold 
<18, 42, <42  S, S, S 
Control 
Toxin +  R 54 serum 
diluted 1/8 
<39, S, S, S, S 
Diluted 
16-fold 
S, S, S 
Normal rabbit serum -]- toxin 
After incubation,  further diluted in yolk and fluids 
Undiluted  I  Diluted 2-fold  Diluted 4-fold 
<14,<14,<14,<14,<14  I  <14,18,18,20, S  ~S-~S~S,S 
The toxin used throughout was a  1/5 yolk sac suspension.  In this table and elsewhere in the 
paper primary, not final, serum dilutions are given. 
*S =  survived. 
:~<  17  :  died in less than 17 hours. 
TABLE  VI 
Cross-Neutralization w~k L.V. and Men. Pn. Antitoxlc Scra 
Serum 
Rabbit 54 bled 
4/15/43 
Rabbit 60 bled 
8f9/43 
Chicken 1 bled 
6/15/45 
Chicken 2 bled 
7/26/43 
L.V. pool 2 
Men. Pn. pool 2 
Tested against 
L.V. toxin  Men. Pn. toxin 
S,* S, S, S, S 
<39,~/S, S, S, S 
S, S, S, S, S 
<17, <17, <17, <17, <41 
<17, <17, <17, 22, <41 
S, S, S, S 
23, S, S, S 
<19, <19, <19, <43, S 
<19, <19, <19, <19, <19 
<19, <43, S, S, S 
<19, <19, S, S, S 
<18, <18, <18, <18, <18 
<18, <18, <18, <18, <18 
<18, <18, <18, <18, <18 
<16, <16,  <16,  <16, <16, <16 
<16, <16, <16, <16, <16 
S, S, S, S, S 
<42, <42, <42,  <42, <42, 48, <66 
<17, <17, 21, 25, 25, <42 
<17, <17, <41, <65, <65 
<17,  <17, <41, <65 
S, S, S, S, S 
<16, S, S, S, S 
<17, <17, <17, <17 
<16,  <16, <16, <16, <16 
<41, S, S, S, S 
S,S, S, S, S 
<18, 26, <41, <41, S 
<18, <18, 22, <41 
Approximately 2  lethal doses of toxin, as shown in control  mice inoculated at the same 
time, were used in all instances. 
* S  =  survived the effects of  the toxin.  (In  the case of L.V.  this  means survival  for 
over 21  days.  In the case of Men. Pn.  it means survival for 50 hours: most of  the mice 
died later, i.e., usually at 5  days or later, from infection.) 
<39  =  died in under 39 hours. 
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neutralization and, as is apparent, this is very slight (in dilution of only 1 in 2 
with the heterologous toxin compared to 1 in 100 with the homologous). 
In the above cases hyperimmune sera from animals apparently not infected 
were uti]ized.  Some studies have been made with human sera from individuals 
infected with, or recovered from, ]ymphogranuloma venereum, psittacosis, and 
trachoma.  All of these sera gave good fixation of complement with yolk sac 
antigen  prepared  against  lymphogranuloma venereum.  3 
Sera have been tested from 11 cases of lymphogranuloma  venereum, a  Ten of these 
gave neutralization  against homologous toxin in dilutions of 1 in 2 or 1 in 10 and none 
neutralized  the meningopneumonitis  toxin.  One (Table  VII) showed no significant 
neutralization  of either  toxin.  It was taken from a case of lymphogranuloma vene- 
reum of less than 1 month's duration which still showed the primary lesion.  A later 
specimen from this case gave homologous neutralization.  Eleven sera from cases of 
atypical pneumonia not due to any one of this group of agents s have been tested  and 
none gave any neutralization.  Two sera from cases of trachoma  8 failed to give any 
neutralization.  Six  sera  from  individuals  recovered  from  psittacosis ~ have  been 
tested and none of these gave any significant neutralization  against the toxins of either 
lymphogranuloma venereum or meningopneumonitis. 
The fact that none of the sera from individuals recovered from psittacosis 
gave significant neutralization is interesting.  It is  true that 3  of these sera 
had been stored for between 1 and 2 years before testing and there might have 
been some loss of antibody in this time.  However, as Table VII shows,  the 
lymphogranuloma serum S.A. had been stored for 3 years and still gave com- 
plete  homologous neutralization at  1 in  10,  and  others  not shown had been 
stored almost as long.  Moreover, in the case of hyperimmune sera, very high 
titers are obtained with meningopneumonitis antisera as compared to antisera 
from lymphogranuloma venereum.  The fact,  therefore,  that  the  sera  from 
human cases of psittacosis fails to give any neutralization with toxin from the 
agent of meningopneumonitis would suggest a distinct difference between these 
Some of these tests were carried  out by Dr. M. F. Shaffer to whom we wish to 
express our thanks. 
Our thanks are due to Dr. A. W. Grace, Long Island College Hospital,  Brooklyn; 
Dr. H. C. de Sousa-Araujo, Institut Oswaldo Cruz, Rio de Janeiro,  Brazil;  Colonel 
W. B. Martin, Percy Jones General Hospital,  Battle Creek, Michigan; and Dr. S. E. 
Sulkin, St. Louis, Missouri, for these specimens of sera. 
5 Our thanks are due to Dr. T. P. Magill of the New York Hospital for these speci- 
mens of sera. 
Our thanks are due to Dr. P. Thygeson,  Presbyterian  Hospital,  New York, for 
these specimens of sera. 
Our thanks are due to Dr. H. A. Schorsh of Cooks County Hospital,  Chicago, 
and Dr. A. M. Williams, Pennsylvania  Department of Health, Pittsburgh, for some 
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two agents, wider than has been supposed by other investigators.  It would 
seem that we are dealing with a  highly specific test,  and this assumption is 
borne out by the cross-neutralization studies with hyperimmune sera already 
described.  Proof must await studies on a larger series of sera. 
As has been pointed out in a preliminary communication (13), mice recovered 
from sublethal doses of the toxin of lymphogranuloma, while not completely 
protected  against  reinoculation with  homologous toxin at  a  later  date,  are 
significantly more resistant than are normal mice.  The same has proven true 
with mice recovered from sublethal doses of the toxin of meningopneumonitis. 
However, no extensive data has been obtained on this point.  One of the chief 
difficulties lies in the circumstance that the first inoculation of toxic material 
sensitizes the mice so that a majority of them, usually about 60 per cent, die 
TABLE  VII 
Neutralizat~a of L.V. and Men, Pn. Toxin with Human Sera 
Serum 
ArI 
~r II 
LA. 
?e 
7406 
Remarks 
Early L.V.  Less than 1 too. 
duration 
Later specimen of above case 
Chronic L.V.  (Stored 3 yrs. 
at 0* before testing) 
Recovered psittacosis. (Stored 
2 yrs. at 0 ° before testing) 
Recovered psittacosis 
Serum 
dilution 
1/2 
1/10 
i/2 
1/10 
I/2 
1/10 
i/2 
1/10 
I/2 
1/10 
Tested against 
L.V. toxin  Men. Pn. toxin 
<15, 22, S, S 
<15, <15, <15, <15 
S, S, S, S, S 
<17, <41, S, S, S 
S, S, S, S, S 
S, S, S, S, S 
<14, <14, <14, <14 
<14, <14, <14, <14 
<18, <18, <18, <18 
<14, <14, <14, <14, 20 
<15, <15, 23, 23 
<15, <15, <15, 19 
<17, <43, <43, <43t 46 
<17, <17, <43, <43, <43 
,  <15, 21, 21, <63, S 
<15, <15, 21, 23, 23 
Approximately 2  lethal doses of toxin, as shown in control mice inoculated at the same 
time, were used in every case. 
from anaphylactic  shock within  a  few minutes  of receiving the  second in- 
travenous inoculation.  This immediate anaphylactic death can be produced 
in these recovered mice with suspensions of normal yolk which never affect 
normal mice.  Since there have never been large numbers of survivors from 
the original inoculation and since approximately 60 per cent of such survivors 
die of shock on challenge inoculation, the number of mice available on which 
to assess  the degree of this acquired immunity has always been small.  No 
evidence of acquired heterologous immunity has been obtained. 
DISCUSSION 
It has been possible to demonstrate for three members of the lymphogranu- 
loma-psittacosis group of agents the presence, in infected chick embryo yolk 
sacs, of a factor very rapidly fatal to mice.  That these rapid deaths are not 
due to infection is shown by six facts.  Foremost is the fact that the deaths GEOFFREY RAKE AND HELEN P.  ~'ONES  481 
occur within 4 hours in the case of one agent (mouse pneumonitis) and within 
12 to 24 hours in the case of the other two.  Infections do not act thus rapidly. 
Moreover, inoculation of two of the agents  (meningopneumonitis and mouse 
pneumonitis)  produces  a  biphasic  curve  of  distribution  of  deaths  and  the 
appearance of the mice dying in the second part of the curve suggests infection. 
Third,  microscopic  examination  of  tissues  from  mice  recently  dead  from 
inoculation of any of the agents gives evidence of infection in the mice dying 
late (during the secondary part of the curves) and only lesions characteristic 
of toxemia in the earlier deaths.  Fourth, meningopneumonitis antitoxic sera, 
which as will be pointed out below, have only a limited degree of power to neu- 
tralize and  prevent the  infection no matter  how high  their antitoxic titers 
may be, blot out the first part of the curve but leave the second unchanged, 
(Text-fig. 2).  Fifth, in the case of lymphogranuloma venereum in which no 
secondary curve of deaths occurs, it has not been possible to demonstrate the 
presence of the agent in a latent form in either the brain or spleen despite the 
ease with which the carrier state is induced following infections with this agent. 
The final evidence lies in experiments described elsewhere (21).  As pointed 
out above, the agent of mouse pneumonltis produces a  biphasic curve of dis- 
tribution of deaths.  Moreover, infections with this agent are susceptible to 
sulfonamide therapy (22).  If our assumptions are correct it should be possible 
to eliminate the second part of the biphasic curve and not affect the first part 
by sul/onamide therapy; and such has proved to be the case. 
These rapid deaths, therefore, are not due to infection and must be due to 
some toxic factor specific for each agent.  The next question to be decided is 
whether these toxic factors are a product of the agents themselves or are pro- 
duced by the action of the agent on the infected yolk cells and are actually 
a product of these cells.  It would seem that the high degree of specificity of 
these toxic factors argues in favor of their being a product of the agents them- 
selves, but more definite evidence than this is required.  This would seem to be 
given by two observations.  Both bear on the fact that, in the case of lympho- 
granu]oma and meningopneumonitis, in which the point has been investigated, 
the  toxic factors are closely associated with  the bodies of the agent.  Thus 
parallel titrations of toxic units for mice and infective units for chick embryos 
indicate that,  in suspensions  of freshly harvested yolk sacs,  the  two bear a 
constant ratio one to the other.  It would seem improbable that, for example, 
1 million infective units of a given agent would always produce the same degree 
of damage in yolk cells and induce the formation of the same amount of toxic 
material from such  cells,  whereas  if the  toxic factor is associated with  the 
bodies of the agents (as an endotoxin) such a constant ratio would be expected. 
Furthermore, differential centrifugations of a character known to separate out 
in the final sediment all the bodies of the agent also separate out in the same 
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likely event that the hypothetical toxic factor from the yolk cells has a  sedi- 
mentation constant similar to the bodies of the agent. 
All of the evidence at present available points to the conclusion that these 
toxic factors are products of the agents themselves.  In this case it would seem 
that they should be known as toxins just as are similar products from other mi- 
croorganisms, i.e.,  bacteria.  Bacterial toxins may be defined as  substances 
elaborated  by  bacteria  which  are  poisonous for  certain  ceils  of susceptible 
animals.  It has been convenient and conventional to divide these toxins into 
the exotoxins which diffuse readily from the living bacteria producing them, 
and endotoxins which remain within the bodies of the living bacteria and are 
liberated only after death and dissolution of the organisms.  The toxins of the 
lymphogranuloma-psittacosis  group  of  agents  would  appear  to  fit  into  the 
general class of endotoxins.  They are not liberated from the bodies of the 
agents under natural conditions and so cannot be termed exotoxins.  In fact it 
has been difficult to show any separation of the toxins from the intact  (and 
infectious) bodies of the agents because of their lability, and partial separation 
has been achieved only by the more delicate of those methods usually employed 
for liberating  endotoxins from bacterial  celJs.  The  minimal  lethal dose  of 
these toxins is large, and they are not very active antigens in the production of 
antitoxic sera, both of which are resemblances to bacterial endotoxins.  Thus, 
as has been pointed out above, while high serum titers can be obtained in the 
case of the meningopneumonitis antitoxin, the neutralization is against  only 
relatively few lethal doses, i.e. between 1 and 4, and the law of neutralization 
in  multiple  proportions  (which  applies  to  exotoxin-antiexotoxin reactions) 
has not been found to apply.  If the dose of toxin from these agents is too 
large, no amount of serum will protect. 
In two ways the toxins of these three agents differ from the more characteris- 
tic bacterial endotoxins.  Thus they are labile to heat and other conditions; 
and they- produce characteristic lesions in mice, particularly in the liver.  On 
the whole, however, it would appear that there is much to relate the toxins to 
bacterial endotoxins and little ground on which to separate them. 
Certain features as regards the neutralization of these toxins with antisera 
are of interest.  As has been pointed out above, although for reasons of con- 
venience neutralizations are carried out in the test tube at room temperature 
and the mixtures later tested for toxicity by inoculation into mice, it is readily 
possible to immunize the animal passively (and in this way carry out the neu- 
tralization tests) either by inoculation of both toxin and antitoxin at different 
times but by the same route (i.e. intravenous) or by inoculation of the antitoxin 
intravenously at the time the mouse receives the toxin intraperitoneally.  Thus 
the possibility that such neutralization as has been demonstrated is due to a 
purely  artificial  reaction in  vitro,  analogous  for  example  to  the  precipitin- 
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It has been pointed out that the antitoxins we have been using have little 
power to prevent infection in, for example, meningopneumonitis, since the mice 
surviving sublethal doses of toxin die later from infection.  In most cases sera 
have been prepared in rabbits.  However, following upon the report of Phair, 
Smith, and Root  (23)  on the high specificity obtained with chicken sera pre- 
pared  against  the  meningococcus,  a  few  sera  were  prepared  in  chickens. 
Because of the susceptibility of chickens to ornithosis (24) and because of the 
demonstrated close relationship between members of  the lymphogranuloma- 
psittacosis group of agents  (1-5), it was decided to use only toxoid in these 
chickens.  Following the use of toxoid, antitoxins have been obtained from 
chickens which have titers as high as those induced by inoculation of toxins, 
and far higher than those induced by inoculation of toxoids, in rabbits.  It is 
possible that the use of untreated toxin in chickens would allow the production 
of still more active sera which would have the power of preventing infection 
as do the chicken sera described by Hilleman and Gordon in a  recent article 
(25), (which appeared after the present work had been completed).  It should 
be pointed out  that  the neutralization tests in the present paper have been 
carried out by varying the dilutions of sera, whether chicken or rabbit, against 
constant  amounts of toxin,  and  never with  undiluted  sera  against  different 
dilutions of toxin. 
The specificity of the hyperimmune sera against these toxins is particularly 
striking in the light of the marked serological cross-reactions between members 
of the group as seen for example in complement fixation tests.  This specificity 
seems also to be a feature of sera obtained from persons suffering from infection 
with members of the group.  In fact this marked specificity may be the reason 
why sera from persons recovered from psittacosis fail to neutralize the toxin of 
meningopneumonitis, and may serve to place this latter agent in a  category 
separate from psittacosis--a point on which there has been some controversy. 
It seems possible that the toxin-antitoxin reaction here described may offer a 
better method of distinguishing  clearly between the different members of the 
lymphogranuloma-psittacosis group than  any hitherto available,  s 
In choosing yolk sacs to use in the preparation of toxin it  has been found 
advisable to select them on the basis of smears of the sacs prepared in a routine 
manner and stained with Macchiavello's stain.  Experience has  taught that 
only yolk sacs giving heavy smears should be used since these are indicative of 
s While the present work was in press work was carried out with the agent of feline 
pneumonitis (26, 27), recently shown to belong to the lymphogranuloma-psittacosis 
group of agents (28).  A toxin similar in many regards to the three described in this 
paper has been found associated with this agent.  As in the case of the other toxins, 
the  toxin-antitoxin reaction with the agent of feline pneumonitis  has been highly 
specific.  The pathological  picture in mice has differed in some respects  from that 
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the  heaviest  infection.  In  this  connection it  should be  reiterated  that  the 
smears from eggs infected with lymphogranuloma will appear more heavily 
infected than those infected with meningopneumonitis which in turn give heav- 
ier smears than those infected with mouse pneumonitis.  This is true despite 
the fact that the infective unit of the agent of meningopneumonitis, for example, 
is present in higher concentration in  the  cells of the yolk sac  than that  of 
lymphogranuloma (some 3- to 6-fold higher--see Table I).  The fewer bodies 
of the agent seen in the smears may be due to differences in physical properties 
preventing the bodies of the agent of meningopneumonitis from being dispersed 
as readily from ruptured cells.  A  suggestion of this is also apparent in the 
morphology of the latter agent as seen in smears.  Thus initial bodies seem to 
be more plentiful and tend to appear in clusters more frequently than is the 
case in lymphogranuloma venereum.  In the case of mouse pneumonitis all 
forms suggestive of a developmental cycle similar to that described for lympho- 
granuloma (10)  can be seen in the smears but it has been observed that the 
elementary bodies of this agent are characteristically smaller than are those of 
the other two and approach more closely the limit of clear resolution. 
SUMMARY 
Toxins, which resemble in most respects bacterial endotoxins, are associated 
with  the  agents  of  lymphogranuloma  venereum,  meningopneumonitis,  and 
mouse pneumonitis as they grow in the yolk sac of the chick embryo.  They 
are labile and are not readily separated from the bodies of the agent.  They 
kill mice rapidly after intravenous,  and  in some  cases after intraperitoneal, 
injection but the minimal lethal dose is relatively large and, in those freshly 
harvested yolk sacs which have been  tested,  has  corresponded to about  36 
million infective units.  Characteristic lesions are produced in all mice except 
those which die very rapidly, and are found especially in the fiver where ne- 
crosis of the midzone of the lobule occurs. 
Antitoxic sera which are effective against a few lethal doses of the toxin can 
be produced in rabbits or chickens by using either toxin or toxoid as antigen. 
Such sera behave in a  manner analogous to antiendotoxins against bacterial 
endotoxins and  they do  not  neutralize by the  law  of multiple proportions. 
Antitoxic sera can also be obtained from human beings convalescent from at 
least  one of these diseases.  The toxins and  antitoxins appear  to be highly 
specific and they may offer a  useful tool in distinguishing between different 
members of this closely interrelated group. 
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EXPLANATION OF PLATE 7 
All of the sections were stained with eosin and methylene blue. 
FIG. 1. Lymphogranuloma venereum toxin.  Earliest lesion  in liver showing  fat 
globules in the cells.  X 100. 
FIG. 2.  Lymphogranuloma venereum toxin.  Liver showing  commencing necrosis 
involving small groups of cells.  X 100. 
FIG. 3.  Meningopneumonitis  toxin.  Liver showing  extensive midzonal necrosis. 
X  100. 
FIG. 4.  Meningopneumonitis toxin. 
Malpighian corpuscle.  X 100. 
FIG. 5.  Meningopneumonitis toxin. 
at 60 to 72 hours.  X 100. 
FIG. 6.  Meningopneumonitis toxin. 
muscle and pericarditis.  X 100. 
Spleen showing almost complete necrosis of a 
Brain showing earliest evidence of meningitis 
Areas of monocytic infiltration of the cardiac THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL, 79  PLATE  7 
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